Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Submits Aries System, Herpes Assay for FDA Clearance

NEW YORK (GenomeWeb) – Luminex today announced that it has submitted 510(k) applications to the US Food and Drug Administration for the firm's Aries platform and HSV 1&2 Assay.

Aries is a cartridge-based, sample-to-answer system that uses real-time PCR for detection and quantification of nucleic acid targets. It offers higher throughput than the firm's earlier-generation xTag platform, but does not offer the same degree of multiplexing. The Aries platform also includes a built-in touchscreen computer.

"In Aries, we believe we have a truly differentiated product that will resonate quite favorably with laboratory customers," Luminex CEO Homi Shamir said in a statement. "As we near the commercial launch of the system, scheduled for later this year, we are excited to enter the next phase of the company's future, with an ever-increasing focus on the molecular diagnostics market, rapidly expanding the Aries menu and driving top-line revenue growth." 

Luminex said it anticipates receiving FDA clearance and CE-IVD marking by the end of the year. Clinical trials for Aries Clostridium difficile and Group B Streptococcus assays are in progress and the firm expects to launch trials for more assays by the end of the year.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.